This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Patient-Controlled Analgesia Pumps Market

Market Insights on Patient-Controlled Analgesia Pumps covering sales outlook, demand forecast & up-to-date key trends

Patient-Controlled Analgesia Pumps Market by Product Type, Application, End and By Region- Forecast for 2022 – 2032

Patient-Controlled Analgesia Pumps Market Size - Industry Outlook 2022 -2032

The global patient-controlled analgesia pumps market is set to enjoy a valuation of US$ 421.9 Mn in 2022, and further expand at a CAGR of 5.2% to reach US$ 699.9 Mn by the year 2032. According to a recent study by Future Market Insights, PCA pumps are leading the market with a share of around 75.5% in 2021, globally.

Market Outlook:

Data Points

Market Insights

Market Value 2021

US$ 398.7 Mn

Market Value 2022

US$ 421.9 Mn

Market Value 2032

US$ 699.9 Mn

CAGR 2022-2032

5.2%

Market Share of Top 5 Countries

56.2%

Key Market Players

Smiths Group plc., Fresenius Kabi Group, Hospira (Pfizer Inc.), Micrel Medical Devices, Ace Medical Co. Ltd., Terumo Corporation, B.Braun Melsungen AG, Baxter International, Becton Dickinson and Company., BD, ICU Medical.

The market value for patient-controlled analgesia pumps market holds approximately 13.5% of the overall US$ 2.96 Bn global analgesia infusion pumps market in 2021.

The rising prevalence of chronic diseases leads to an increase in the number of surgeries performed around the world, which is likely to drive market expansion. Over the projected period, the market for patient-controlled analgesia pumps market is expected to develop due to an increase in the incidence of cancer cases.

For instance, cardiovascular disorders have become one of the leading causes of death and morbidity in the previous three decades.

Furthermore, According to the American Heart Association (AHA), in 2021, Cardiovascular Disease (CVD) affects about 92.1 million individuals in the United States, and it is the leading cause of death in the country when compared to other chronic conditions.

Acute, chronic, postoperative, and labour pain may be treated with patient-controlled analgesia pumps, especially in patients who are unable to accept oral drugs. Patient-controlled analgesia pumps can be utilized to lessen the strain on both the patient and the nursing staff of having to follow a predetermined dose schedule of needed analgesics that might not be sufficiently aligned with the patient's fluctuating pain levels.

While sustained opioid dose has been shown to enhance patient outcomes, patient-controlled analgesia pumps can be helpful in the acute pain scenario when the initial opioid delivery in the emergency department failed to adequately control pain. The vaso-occlusive pain crises, trauma, pancreatitis, or burns are typical examples. To manage the pain while treatment, infusion pumps would be utilized as an additional therapy.

It will thus help the market to further grow, by improving the product offering in the market by the key players during the forecast period from 2022 to 2032.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Patient-Controlled Analgesia Pumps from 2012 to 2021 vs. Market Outlook for 2022 to 2032

The sales of patient-controlled analgesia pumps have expanded in recent years, owing to the increased adoption of advanced patient-controlled analgesia pumps. With the advantages of analgesia pumps such as ease of transport and fast delivery of required drugs at the right place, over other available devices found in the market, will lead to growth in this segment.

Over 50% of hospitalization cases are caused by pain, making it one of the leading causes of hospital visits. Furthermore, 33% of cancer survivors are thought to experience persistent pain, necessitating therapy and the direct administration of medications to provide quick relief.

By using a programmable pump to self-administer intravenous opioids, PCA pumps manage cancer pain. Patients who experience moderate to severe pain from cancer utilize patient-controlled analgesia pumps at home.

Over the forecast period, the market for analgesia pumps devices is expected to be influenced by product innovation and advancement. Technology is projected to progress quickly, encouraging businesses to introduce more user-friendly and sophisticated analgesia pump systems.

Companies are working to integrate comprehensive drug libraries into pumps, offer multidirectional interoperability, and safeguard patient and instrument data (better electronic health record management). These are anticipated to improve medication administration in various care settings. Drug distribution to incorrect patients can be avoided with smart pumps that have DEES and BPOC, improving patient safety. This is anticipated to be a key element influencing the market for patient-controlled analgesia pumps.

  • In March 2022, Fresenius Kabi's wireless Agilia System received FDA 510(k) clearance.

Thus, all the above factors offer great opportunities for the market to grow at a CAGR of 5.2% from 2022 to 2032 globally.

Patient-Controlled Analgesia Pumps Market Download Report Brochure

What are the Key Opportunities for Patient-Controlled Analgesia Pumps Manufacturers?

With the sharp increase in the prevalence of diseases including cancer, diabetes, and chronic pain patient, demand for controlled analgesia pumps is increasing. Leading manufacturers are extending their production capacity by establishing new manufacturing facilities where it will be simple to produce smart analgesia pump systems with cutting-edge technical features to meet the market's increasing demand for these patient-controlled analgesia pumps.

Emerging nations in Asia, primarily China and India, as well as East Africa, including Kenya and Nigeria, are hotspots for investment potential due to their high rates of chronic disease incidence, expanding collaborations, and modernization of healthcare systems.

Collaborative research between two major players in the infusion pumps market is gaining traction in developed markets. In the process, both companies share their resources to develop a technologically advanced product. Collaborative research is most noted for indications which have a high incidence, such as diabetes.

In Jan 2022, ICU Medical Inc. completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately $2.5 billion.

A more positive patient experience and level of satisfaction are influenced by comfortable pain management. Patients and trained caregivers can easily handle analgesia pumps. To boost their brand image among consumers, hospitals are putting more and more emphasis on enhancing patient safety and comfort. Increasing focus on better patient access and satisfaction will help in boosting the market.

All the above scenarios offer a great opportunity for market growth during the forecast period from 2022 to 2032.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Demand for Patient-Controlled Analgesia Pumps?

Due to the rising incidence of diabetes and trauma, as well as the growing senior population, there is an urgent need for qualified specialists and professionals on a global scale. However, the lack of skilled workers and operators will restrain the market's expansion for patient-controlled analgesia pumps.

Both in developed and emerging countries, there is a great demand for experts and specialists. Despite significant investments, the global patient-controlled analgesia pumps market's expansion would be constrained over the projected period by a lack of skilled specialists and professionals.

Patient-controlled analgesia pumps are not consistently used, and there is currently a lack of sufficient documentation regarding their use and the accessibility to pharmacological libraries. It is crucial to standardize the equipment used in hospitals' many departments, including paediatrics, critical care, and others.

The demand for advanced patient-controlled analgesia pumps may be hampered, and the market growth for patient-controlled analgesia pumps may be constrained throughout the projected period, by the lack of adequate healthcare infrastructure in growing areas including the Middle East, Africa, and Latin America.

The development of the patient-controlled analgesia pumps market in the area is further hampered by the absence of an appropriate regulatory framework for medical operations including the use of patient-controlled analgesia pumps.

Country-wise Insights

What Makes the U.S. the Largest Market for Patient-Controlled Analgesia Pumps?

The U.S. rules the North American region with a global market share of about 35.5% in 2021 and is expected to continue to experience the same growth throughout the forecast period. The U.S. is the most lucrative market for patient-controlled analgesia pumps owing to the high prevalence rate of chronic disorders in the region.

For instance, In 2019, the ninth most common cause of death in the U.S. was chronic kidney disease, which is at risk in about 80.0 million people, or almost one in three American adults. This has led to an observed impact on an increase in the number of cases involving kidney failure within the country, and hence, this factor is likely to translate into a propelling factor for different surgeries, and subsequently, growth in the market for patient-controlled analgesia pumps.

Why Germany is considered a Lucrative Market for Patient-Controlled Analgesia Pumps?

Germany contributes approximately 7.2% of the value share to the global market in 2021, for the patient-controlled analgesia pumps market and is estimated to grow and provide lucrative opportunities to the market players during the forecast period. This is due to the increasing number of cancer cases in this region.

According to the WHO 2020 Report, there have been over 628,519 new cancer cases reported in Germany. Such occurrences point to a considerable expansion of the patient-controlled analgesia pumps market. Because of this, the use of analgesia pumps is increasing over time. Thus, it boosts the market to grow forward during the forecast period from 2022 to 2032 in the region.

What Makes China an Emerging Market for Patient-Controlled Analgesia Pumps?

China held around 5.5% share in the global patient-controlled analgesia pumps market in 2021 and this share is projected to increase at a high rate during the forecast period. This growth is associated with increasing advancements in technologies for analgesia pumps within the country. The main factor responsible for this growth is a large geriatric age group population within the country.

As per the WHO, in 2019, there were 176 million older individuals who were 65 years or older age and 254 million persons who were 60 years of age or older. Hence, the market for patient-controlled analgesia pumps is growing favourably because of the rising geriatric population's increased risk of chronic diseases.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Which Product in the Patient-Controlled Analgesia Pumps Market is Driving Market Growth?

PCA Pumps project lucrative growth with a market share of over 75% in 2021.

PCA pump is a computerized device that is directly attached to the patient's IV (intravenous) line and includes a syringe filled with painkillers as prescribed by a doctor. Physicians prescribe extremely potent opioid medications, such as hydromorphine, morphine, and fentanyl via patient-controlled analgesia pumps, to relieve the excruciating pain. Increased use of PCA pumps in these circumstances to improve quality of life is predicted to drive market expansion.

Which application is of large focus in the Patient-Controlled Analgesia Pumps Market?

Chemotherapy/Oncology held a revenue share of 36.6% in 2021 and is expected to increase over the forecast period with a CAGR rate of 4.9% during the forecast period.

During the forecast period, it is anticipated that the oncology application category would account for the greatest revenue share of the market. This dominance is a result of its expanding use of patient-controlled analgesia pumps in the treatment of chronic cancer pain. Physicians prescribe extremely potent opioid medications, such as hydromorphine, morphine, and fentanyl via patient-controlled analgesia pumps, to relieve the excruciating pain. The growing use of PCA pumps in these circumstances to improve quality of life is anticipated to drive segment growth.

Which End User Benefits the Most in the Patient-Controlled Analgesia Pumps Market?

Hospitals are the leading segment in the patient-controlled analgesia pumps market with a 56.9% market share in 2021 and are expected to hold a similar share over the forecast period growing at a CAGR of 5.4% in 2032.

The availability of advanced medical equipment with improved efficiency and technology along with trained staff and healthcare professionals add to the high growth of this segment. The presence of advanced medical equipment attracts a large number of patients to come to hospitals to seek treatment and get maximum satisfaction and relief. Thus, hospitals are ahead of other end users in the patient-controlled analgesia pumps market.

Competitive Landscape

Key players in the patient-controlled analgesia pumps market are focusing on expanding their presence globally as well as offerings the products as the key strategies.

These factors will help market players to enhance their product portfolio together with penetration in the market thereby, increasing their overall revenue share in the global patient-controlled analgesia pumps market.

Given below are a few examples of the key strategies followed by the manufacturers:

  • On December 2017, announced that Sheridan Memorial Hospital in Sheridan, Wyoming, successfully integrated ICU Medical’s LifeCare PCA™7.0 infusion system with Cerner Millennium, Cerner’s core electronic health record (EHR) solution. This announcement marks the first time a patient-controlled analgesia (PCA) pump has been integrated with Sheridan Memorial through Cerner’s EHR technology.
  • On April 1, 2022, Smiths Medical announced a partnership with Bainbridge Health. The partnership focused on providing pharmacy and safety leaders with visibility into emerging trends in intravenous medication safety and utilization.
  • In January 2022, BD came into a definitive agreement to acquire Parata Systems, for US$1.525 billion.

Similarly, recent developments related to companies manufacturing patient-controlled analgesia pump products have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as per Patient-Controlled Analgesia Pumps Industry Analysis

Attribute

Details

Forecast Period

2012-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

US, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, U.K., Spain, BENELUX, Russia, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, New Zealand, GCC countries, Turkey, North Africa, and North Africa.

Key Market Segments Covered

Products, Application, End User, and Region

Key Companies Profiled

  • Smiths Group plc.
  • Fresenius Kabi Group,
  • Hospira (Pfizer Inc.),
  • Micrel Medical Devices,
  • Ace Medical Co. Ltd.
  • Terumo Corporation,
  • B.Braun Melsungen AG
  • Baxter International
  • Becton Dickinson and Company.
  • BD
  • ICU Medical

Pricing

Available upon Request

Key Market Segments Covered in Patient-Controlled Analgesia Pumps Industry Research

By Product:

  • PCA Pumps
  • Pump Accessories

By Application:

  • Chemo Therapy/Oncology
  • Pediatrics/Neonatology
  • Gastroenterology
  • Hematology

By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Home care settings

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global patient-controlled analgesia pumps market is worth US$ 398.7 Mn in 2021.

The patient-controlled analgesia pumps market is expected to reach US$ 699.9 Mn by the end of 2032, with sales revenue expected to register an 5.2% CAGR.

Favorable government regulations, developments in analgesia devices, and growing R&D activities for the development of cost-effective and time-efficient services for more effectiveness of patient-controlled analgesia pumps, are some of the key trends being witnessed in this marketplace.

U.S., China, the U.K., Germany, and France are expected to drive demand for the patient-controlled analgesia pumps industry.

U.S. is one of the key markets for patient-controlled analgesia pumps, accounting for nearly 35.5% global revenue share in the year 2021.

Demand for patient controlled analgesia pumps in Europe is expected to register a growth of 5.5% over the next ten years.

The U.S., Germany, and China are key producers of patient-controlled analgesia pumps.

Smiths Group plc. Fresenius Kabi Group, Hospira (Pfizer Inc.), Micrel Medical Devices, Ace Medical Co. Ltd., Terumo Corporation, B.Braun Melsungen AG, Baxter International, Becton Dickinson, and Company., BD, and ICU Medical., are the key exporters of the patient-controlled analgesia pumps market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Regulatory Scenario

    4.2. PESTLE Analysis

    4.3. Porter’s Analysis

    4.4. Value Chain Analysis

    4.5. Key Promotional Strategies by Manufacturers

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Infusion Pumps Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. GDP Growth

        5.2.2. Increasing Investment in R&D Activities

        5.2.3. Increasing Prevalence of Cardiac Diseases

        5.2.4. Increasing Surgical Procedures

        5.2.5. New Product Launch

        5.2.6. Advancement In Technology

        5.2.7. Elevating Awareness About Pain Management

        5.2.8. Adoption Rate of Patient Controlled Analgesia Pumps.

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. Revenue By Product

        6.1.2. Revenue By Application Type

        6.1.3. Revenue By End User

        6.1.4. Revenue By Country

    6.2. 2021 Market Scenario

7. Global Patient-Controlled Analgesia Pumps Market Demand Volume (Units) Analysis 2012–2021 and Forecast, 2022–2032

    7.1. Historical Market Volume (Units) Analysis, 2012–2021

    7.2. Current and Future Market Volume (Units) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Patient-Controlled Analgesia Pumps Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Product

    8.2. Pricing Break Up

        8.2.1. Manufacturer Level

        8.2.2. Distributor Level

    8.3. Global Average Pricing Analysis Benchmark

    8.4. Pricing Assumptions

9. Global Patient-Controlled Analgesia Pumps Market Demand (in Value or Size in US$ Mn) Analysis 2012–2021 and Forecast, 2022–2032

    9.1. Historical Market Value (US$ Mn) Analysis, 2012–2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Patient-Controlled Analgesia Pumps Market Analysis 2012–2021 and Forecast 2022–2032, By Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2012–2021

    10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032

        10.3.1. PCA Pumps

        10.3.2. Pump Accessories

    10.4. Market Attractiveness Analysis By Product

11. Global Patient-Controlled Analgesia Pumps Market Analysis 2012–2021 and Forecast 2022–2032, By Application Type

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn), By Application Type, 2012–2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application Type, 2022–2032

        11.3.1. Chemo Therapy/Oncology

        11.3.2. Pediatrics/Neonatology

        11.3.3. Gastroenterology

        11.3.4. Hematology

    11.4. Market Attractiveness Analysis By Application Type

12. Global Patient-Controlled Analgesia Pumps Market Analysis 2012–2021 and Forecast 2022–2032, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn), By End User, 2012–2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032

        12.3.1. Hospitals

        12.3.2. Ambulatory Surgical Centers

        12.3.3. Home care Settings

    12.4. Market Attractiveness Analysis By End User

13. Global Patient-Controlled Analgesia Pumps Market Analysis 2012–2021 and Forecast 2022–2032, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2012–2021

    13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2022–2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Patient-Controlled Analgesia Pumps Market Analysis 2012–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2012–2021

    14.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032

        14.4.1. By Country

            14.4.1.1. U.S.

            14.4.1.2. Canada

        14.4.2. By Product

        14.4.3. By Application Type

        14.4.4. By End User

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By Application Type

        14.5.4. By End User

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. U.S. Patient-Controlled Analgesia Pumps Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Product

                14.8.1.2.2. By Application Type

                14.8.1.2.3. By End User

        14.8.2. Canada Patient-Controlled Analgesia Pumps Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Product

                14.8.2.2.2. By Application Type

                14.8.2.2.3. By End User

15. Latin America Patient-Controlled Analgesia Pumps Market Analysis 2012–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2012–2021

    15.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032

        15.4.1. By Country

            15.4.1.1. Mexico

            15.4.1.2. Brazil

            15.4.1.3. Argentina

            15.4.1.4. Rest of Latin America

        15.4.2. By Product

        15.4.3. By Application Type

        15.4.4. By End User

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By Application Type

        15.5.4. By End User

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. Mexico Patient-Controlled Analgesia Pumps Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Product

                15.8.1.2.2. By Application Type

                15.8.1.2.3. By End User

        15.8.2. Brazil Patient-Controlled Analgesia Pumps Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Product

                15.8.2.2.2. By Application Type

                15.8.2.2.3. By End User

        15.8.3. Argentina Patient-Controlled Analgesia Pumps Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Product

                15.8.3.2.2. By Application Type

                15.8.3.2.3. By End User

16. Europe Patient-Controlled Analgesia Pumps Market Analysis 2012–2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2012–2021

    16.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032

        16.4.1. By Country

            16.4.1.1. Germany

            16.4.1.2. Italy

            16.4.1.3. France

            16.4.1.4. U.K.

            16.4.1.5. Spain

            16.4.1.6. BENELUX

            16.4.1.7. Russia

            16.4.1.8. Rest of Europe

        16.4.2. By Product

        16.4.3. By Application Type

        16.4.4. By End User

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By Application Type

        16.5.4. By End User

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. Germany Patient-Controlled Analgesia Pumps Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Product

                16.8.1.2.2. By Application Type

                16.8.1.2.3. By End User

        16.8.2. Italy Patient-Controlled Analgesia Pumps Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Product

                16.8.2.2.2. By Application Type

                16.8.2.2.3. By End User

        16.8.3. France Patient-Controlled Analgesia Pumps Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Product

                16.8.3.2.2. By Application Type

                16.8.3.2.3. By End User

        16.8.4. U.K. Patient-Controlled Analgesia Pumps Market Analysis

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast by Market Taxonomy

                16.8.4.2.1. By Product

                16.8.4.2.2. By Application Type

                16.8.4.2.3. By End User

        16.8.5. Spain Patient-Controlled Analgesia Pumps Market Analysis

            16.8.5.1. Introduction

            16.8.5.2. Market Analysis and Forecast by Market Taxonomy

                16.8.5.2.1. By Product

                16.8.5.2.2. By Application Type

                16.8.5.2.3. By End User

        16.8.6. BENELUX Patient-Controlled Analgesia Pumps Market Analysis

            16.8.6.1. Introduction

            16.8.6.2. Market Analysis and Forecast by Market Taxonomy

                16.8.6.2.1. By Product

                16.8.6.2.2. By Application Type

                16.8.6.2.3. By End User

        16.8.7. Russia Patient-Controlled Analgesia Pumps Market Analysis

            16.8.7.1. Introduction

            16.8.7.2. Market Analysis and Forecast by Market Taxonomy

                16.8.7.2.1. By Product

                16.8.7.2.2. By Application Type

                16.8.7.2.3. By End User

17. South Asia Patient-Controlled Analgesia Pumps Market Analysis 2012–2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2012–2021

    17.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032

        17.4.1. By Country

            17.4.1.1. India

            17.4.1.2. Indonesia

            17.4.1.3. Malaysia

            17.4.1.4. Thailand

            17.4.1.5. Rest of South Asia

        17.4.2. By Product

        17.4.3. By Application Type

        17.4.4. By End User

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product

        17.5.3. By Application Type

        17.5.4. By End User

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. India Patient-Controlled Analgesia Pumps Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Product

                17.8.1.2.2. By Application Type

                17.8.1.2.3. By End User

        17.8.2. Indonesia Patient-Controlled Analgesia Pumps Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Product

                17.8.2.2.2. By Application Type

                17.8.2.2.3. By End User

        17.8.3. Malaysia Patient-Controlled Analgesia Pumps Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Product

                17.8.3.2.2. By Application Type

                17.8.3.2.3. By End User

        17.8.4. Thailand Patient-Controlled Analgesia Pumps Market Analysis

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast by Market Taxonomy

                17.8.4.2.1. By Product

                17.8.4.2.2. By Application Type

                17.8.4.2.3. By End User

18. East Asia Patient-Controlled Analgesia Pumps Market Analysis 2012–2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2012–2021

    18.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032

        18.4.1. By Country

            18.4.1.1. China

            18.4.1.2. Japan

            18.4.1.3. South Korea

        18.4.2. By Product

        18.4.3. By Application Type

        18.4.4. By End User

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Product

        18.5.3. By Application Type

        18.5.4. By End User

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. China Patient-Controlled Analgesia Pumps Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Product

                18.8.1.2.2. By Application Type

                18.8.1.2.3. By End User

        18.8.2. Japan Patient-Controlled Analgesia Pumps Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Product

                18.8.2.2.2. By Application Type

                18.8.2.2.3. By End User

        18.8.3. South Korea Patient-Controlled Analgesia Pumps Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast by Market Taxonomy

                18.8.3.2.1. By Product

                18.8.3.2.2. By Application Type

                18.8.3.2.3. By End User

19. Oceania Patient-Controlled Analgesia Pumps Market 2012-2021 and Forecast 2022-2032

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2012–2021

    19.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032

        19.4.1. By Country

            19.4.1.1. Australia

            19.4.1.2. New Zealand

        19.4.2. By Product

        19.4.3. By Application Type

        19.4.4. By End User

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Product

        19.5.3. By Application Type

        19.5.4. By End User

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis & Forecast

        19.8.1. Australia Patient-Controlled Analgesia Pumps Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Product

                19.8.1.2.2. By Application Type

                19.8.1.2.3. By End User

        19.8.2. New Zealand Patient-Controlled Analgesia Pumps Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Product

                19.8.2.2.2. By Application Type

                19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Patient-Controlled Analgesia Pumps Market Analysis 2012–2021 and Forecast 2022–2032

    20.1. Introduction

    20.2. Pricing Analysis

    20.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2012–2021

    20.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022–2032

        20.4.1. By Country

            20.4.1.1. GCC Countries

            20.4.1.2. Turkey

            20.4.1.3. South Africa

            20.4.1.4. Rest of Middle East and Africa

        20.4.2. By Product

        20.4.3. By Application Type

        20.4.4. By End User

    20.5. Market Attractiveness Analysis

        20.5.1. By Country

        20.5.2. By Product

        20.5.3. By Application Type

        20.5.4. By End User

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

    20.8. Country Level Analysis & Forecast

        20.8.1. GCC Countries Patient-Controlled Analgesia Pumps Market Analysis

            20.8.1.1. Introduction

            20.8.1.2. Market Analysis and Forecast by Market Taxonomy

                20.8.1.2.1. By Product

                20.8.1.2.2. By Application Type

                20.8.1.2.3. By End User

        20.8.2. Turkey Patient-Controlled Analgesia Pumps Market Analysis

            20.8.2.1. Introduction

            20.8.2.2. Market Analysis and Forecast by Market Taxonomy

                20.8.2.2.1. By Product

                20.8.2.2.2. By Application Type

                20.8.2.2.3. By End User

        20.8.3. South Africa Patient-Controlled Analgesia Pumps Market Analysis

            20.8.3.1. Introduction

            20.8.3.2. Market Analysis and Forecast by Market Taxonomy

                20.8.3.2.1. By Product

                20.8.3.2.2. By Application Type

                20.8.3.2.3. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of Top Players

    21.3. Market Presence Analysis

        21.3.1. Regional Footprint Analysis

        21.3.2. Product Footprint Analysis

        21.3.3. Channel Footprint Analysis

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Key Development Analysis

    22.4. Competition Deep Dive

        22.4.1.     Smiths Group plc.

            22.4.1.1. Overview

            22.4.1.2. Product Portfolio

            22.4.1.3. Key Financial

            22.4.1.4. Sales Footprint

            22.4.1.5. Key Developments

            22.4.1.6. SWOT Analysis

            22.4.1.7. Strategy Overview

                22.4.1.7.1. Marketing Strategies

                22.4.1.7.2. Product Strategies

                22.4.1.7.3. Channel Strategies

        22.4.2. Fresenius Kabi Group,

            22.4.2.1. Overview

            22.4.2.2. Product Portfolio

            22.4.2.3. Key Financial

            22.4.2.4. Sales Footprint

            22.4.2.5. Key Developments

            22.4.2.6. SWOT Analysis

            22.4.2.7. Strategy Overview

                22.4.2.7.1. Marketing Strategies

                22.4.2.7.2. Product Strategies

                22.4.2.7.3. Channel Strategies

        22.4.3. Hospira (Pfizer Inc.),

            22.4.3.1. Overview

            22.4.3.2. Product Portfolio

            22.4.3.3. Key Financial

            22.4.3.4. Sales Footprint

            22.4.3.5. Key Developments

            22.4.3.6. SWOT Analysis

            22.4.3.7. Strategy Overview

                22.4.3.7.1. Marketing Strategies

                22.4.3.7.2. Product Strategies

                22.4.3.7.3. Channel Strategies

        22.4.4. Micrel Medical Devices,

            22.4.4.1. Overview

            22.4.4.2. Product Portfolio

            22.4.4.3. Key Financial

            22.4.4.4. Sales Footprint

            22.4.4.5. Key Developments

            22.4.4.6. SWOT Analysis

            22.4.4.7. Strategy Overview

                22.4.4.7.1. Marketing Strategies

                22.4.4.7.2. Product Strategies

                22.4.4.7.3. Channel Strategies

        22.4.5. Ace Medical Co. Ltd.

            22.4.5.1. Overview

            22.4.5.2. Product Portfolio

            22.4.5.3. Key Financial

            22.4.5.4. Sales Footprint

            22.4.5.5. Key Developments

            22.4.5.6. SWOT Analysis

            22.4.5.7. Strategy Overview

                22.4.5.7.1. Marketing Strategies

                22.4.5.7.2. Product Strategies

                22.4.5.7.3. Channel Strategies

        22.4.6. Terumo Corporation,

            22.4.6.1. Overview

            22.4.6.2. Product Portfolio

            22.4.6.3. Key Financial

            22.4.6.4. Sales Footprint

            22.4.6.5. Key Developments

            22.4.6.6. SWOT Analysis

            22.4.6.7. Strategy Overview

                22.4.6.7.1. Marketing Strategies

                22.4.6.7.2. Product Strategies

                22.4.6.7.3. Channel Strategies

        22.4.7. B.Braun Melsungen AG

            22.4.7.1. Overview

            22.4.7.2. Product Portfolio

            22.4.7.3. Key Financial

            22.4.7.4. Sales Footprint

            22.4.7.5. Key Developments

            22.4.7.6. SWOT Analysis

            22.4.7.7. Strategy Overview

                22.4.7.7.1. Marketing Strategies

                22.4.7.7.2. Product Strategies

                22.4.7.7.3. Channel Strategies

        22.4.8. Baxter International

            22.4.8.1. Overview

            22.4.8.2. Product Portfolio

            22.4.8.3. Key Financial

            22.4.8.4. Sales Footprint

            22.4.8.5. Key Developments

            22.4.8.6. SWOT Analysis

            22.4.8.7. Strategy Overview

                22.4.8.7.1. Marketing Strategies

                22.4.8.7.2. Product Strategies

                22.4.8.7.3. Channel Strategies

        22.4.9. Becton Dickinson and Company.

            22.4.9.1. Overview

            22.4.9.2. Product Portfolio

            22.4.9.3. Key Financial

            22.4.9.4. Sales Footprint

            22.4.9.5. Key Developments

            22.4.9.6. SWOT Analysis

            22.4.9.7. Strategy Overview

                22.4.9.7.1. Marketing Strategies

                22.4.9.7.2. Product Strategies

                22.4.9.7.3. Channel Strategies

        22.4.10. BD

            22.4.10.1. Overview

            22.4.10.2. Product Portfolio

            22.4.10.3. Key Financial

            22.4.10.4. Sales Footprint

            22.4.10.5. Key Developments

            22.4.10.6. SWOT Analysis

            22.4.10.7. Strategy Overview

                22.4.10.7.1. Marketing Strategies

                22.4.10.7.2. Product Strategies

                22.4.10.7.3. Channel Strategies

        22.4.11. ICU Medical

            22.4.11.1. Overview

            22.4.11.2. Product Portfolio

            22.4.11.3. Key Financial

            22.4.11.4. Sales Footprint

            22.4.11.5. Key Developments

            22.4.11.6. SWOT Analysis

            22.4.11.7. Strategy Overview

                22.4.11.7.1. Marketing Strategies

                22.4.11.7.2. Product Strategies

                22.4.11.7.3. Channel Strategies

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 02: Global Patient-Controlled Analgesia Pumps Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 03: Global Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application type

Table 04: Global Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 05: Global Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Region

Table 06: North America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis 2012–2032and Forecast 2022–2032, by Country

Table 07: North America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 08: North America Patient-Controlled Analgesia Pumps Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 09: North America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application type

Table 10: North America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 11: Latin America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis 2012–2032and Forecast 2022–2032, by Country

Table 12: Latin America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 13: Latin America Patient-Controlled Analgesia Pumps Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 14: Latin America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application type

Table 15: Latin America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 16: Europe Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis 2012–2032and Forecast 2022–2032, by Country

Table 17: Europe Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 18: Europe Patient-Controlled Analgesia Pumps Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 19: Europe Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application type

Table 20: Europe Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 21: South Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis 2012–2032and Forecast 2022–2032, by Country

Table 22: South Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 23: South Asia Patient-Controlled Analgesia Pumps Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 24: South Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application type

Table 25: South Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 26: East Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis 2012–2032and Forecast 2022–2032, by Country

Table 27: East Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 28: East Asia Patient-Controlled Analgesia Pumps Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 29: East Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application type

Table 30: East Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 31: Oceania Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis 2012–2032and Forecast 2022–2032, by Country

Table 32: Oceania Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 33: Oceania Patient-Controlled Analgesia Pumps Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 34: Oceania Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application type

Table 35: Oceania Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 36: MEA Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis 2012–2032and Forecast 2022–2032, by Country

Table 37: MEA Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 38: MEA Patient-Controlled Analgesia Pumps Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 39: MEA Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Application type

Table 40: MEA Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Patient-Controlled Analgesia Pumps Market Volume (Units), 2012 – 2021

Figure 02: Global Patient-Controlled Analgesia Pumps Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022–2032

Figure 03: Patient-Controlled Analgesia Pumps Market, Pricing Analysis per unit (US$), in 2022

Figure 04: Patient-Controlled Analgesia Pumps Market, Pricing Forecast per unit (US$), in 2032

Figure 05: Global Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis, 2012 – 2021

Figure 06: Global Patient-Controlled Analgesia Pumps Market Forecast & Y-o-Y Growth, 2022–2032

Figure 07: Global Patient-Controlled Analgesia Pumps Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032

Figure 08: Global Patient-Controlled Analgesia Pumps Market Value Share (%) Analysis 2022 and 2032, by Product

Figure 09: Global Patient-Controlled Analgesia Pumps Market Y-o-Y Growth (%) Analysis 2021-2032, by Product

Figure 10: Global Patient-Controlled Analgesia Pumps Market Attractiveness Analysis 2022–2032, by Product

Figure 11: Global Patient-Controlled Analgesia Pumps Market Value Share (%) Analysis 2022 and 2032, by Application type

Figure 12: Global Patient-Controlled Analgesia Pumps Market Y-o-Y Growth (%) Analysis 2021-2032, by Application type

Figure 13: Global Patient-Controlled Analgesia Pumps Market Attractiveness Analysis 2022–2032, by Application type

Figure 14: Global Patient-Controlled Analgesia Pumps Market Value Share (%) Analysis 2022 and 2032, by End User

Figure 15: Global Patient-Controlled Analgesia Pumps Market Y-o-Y Growth (%) Analysis 2021-2032, by End User

Figure 16: Global Patient-Controlled Analgesia Pumps Market Attractiveness Analysis 2022–2032, by End User

Figure 17: Global Patient-Controlled Analgesia Pumps Market Value Share (%) Analysis 2022 and 2032, by Region

Figure 18: Global Patient-Controlled Analgesia Pumps Market Y-o-Y Growth (%) Analysis 2021-2032, by Region

Figure 19: Global Patient-Controlled Analgesia Pumps Market Attractiveness Analysis 2022–2032, by Region

Figure 20: North America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis, 2012 – 2021

Figure 21: North America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Forecast, 2022-2032

Figure 22: North America Patient-Controlled Analgesia Pumps Market Value Share, by Product (2022 E)

Figure 23: North America Patient-Controlled Analgesia Pumps Market Value Share, by Application type (2022 E)

Figure 24: North America Patient-Controlled Analgesia Pumps Market Value Share, by End User (2022 E)

Figure 25: North America Patient-Controlled Analgesia Pumps Market Value Share, by Country (2022 E)

Figure 26: North America Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Product, 2022–2032

Figure 27: North America Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Application type, 2022–2032

Figure 28: North America Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by End User, 2022–2032

Figure 29: North America Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Country, 2022–2032

Figure 30: U.S. Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 31: Global Vs. U.S. Growth Comparison, 2021 - 2032

Figure 32: U.S. Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 33: U.S. Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 34: U.S. Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 35: Canada Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 36: Global Vs. Canada. Growth Comparison, 2021 - 2032

Figure 37: Canada Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 38: Canada Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 39: Canada Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 40: Latin America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis, 2012 – 2021

Figure 41: Latin America Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Forecast, 2022-2032

Figure 42: Latin America Patient-Controlled Analgesia Pumps Market Value Share, by Product (2022 E)

Figure 43: Latin America Patient-Controlled Analgesia Pumps Market Value Share, by Application type (2022 E)

Figure 44: Latin America Patient-Controlled Analgesia Pumps Market Value Share, by End User (2022 E)

Figure 45: Latin America Patient-Controlled Analgesia Pumps Market Value Share, by Country (2022 E)

Figure 46: Latin America Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Product, 2022–2032

Figure 47: Latin America Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Application type, 2022–2032

Figure 48: Latin America Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by End User, 2022–2032

Figure 49: Latin America Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Country, 2022–2032

Figure 50: Mexico Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 51: Global Vs. Mexico Growth Comparison, 2021 - 2032

Figure 52: Mexico Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 53: Mexico Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 54: Mexico Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 55: Brazil Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 56: Global Vs. Brazil. Growth Comparison, 2021 - 2032

Figure 57: Brazil Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 58: Brazil Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 59: Brazil Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 60: Argentina Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 61: Global Vs. Argentina Growth Comparison, 2021 - 2032

Figure 62: Argentina Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 63: Argentina Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 64: Argentina Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 65: Europe Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis, 2012 – 2021

Figure 66: Europe Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Forecast, 2022-2032

Figure 67: Europe Patient-Controlled Analgesia Pumps Market Value Share, by Product (2022 E)

Figure 68: Europe Patient-Controlled Analgesia Pumps Market Value Share, by Application type (2022 E)

Figure 69: Europe Patient-Controlled Analgesia Pumps Market Value Share, by End User (2022 E)

Figure 70: Europe Patient-Controlled Analgesia Pumps Market Value Share, by Country (2022 E)

Figure 71: Europe Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Product, 2022–2032

Figure 72: Europe Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Application type, 2022–2032

Figure 73: Europe Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by End User, 2022–2032

Figure 74: Europe Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Country, 2022–2032

Figure 75: UK Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 76: Global Vs. UK Growth Comparison, 2021 - 2032

Figure 77: UK Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 78: UK Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 79: UK Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 80: Germany Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 81: Global Vs. Germany Growth Comparison, 2021 - 2032

Figure 82: Germany Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 83: Germany Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 84: Germany Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 85: Italy Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 86: Global Vs. Italy Growth Comparison, 2021 - 2032

Figure 87: Italy Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 88: Italy Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 89: Italy Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 90: France Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 91: Global Vs. France Growth Comparison, 2021 - 2032

Figure 92: France Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 93: France Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 94: France Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 95: Spain Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 96: Global Vs. Spain Growth Comparison, 2021 - 2032

Figure 97: Spain Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 98: Spain Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 99: Spain Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 100: Russia Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 101: Global Vs. Russia Growth Comparison, 2021 - 2032

Figure 102: Russia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 103: Russia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 104: Russia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 105: BENELUX Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 106: Global Vs. BENELUX Growth Comparison, 2021 - 2032

Figure 107: BENELUX Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 108: BENELUX Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 109: BENELUX Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 110: East Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis, 2012 – 2021

Figure 111: East Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Forecast, 2022-2032

Figure 112: East Asia Patient-Controlled Analgesia Pumps Market Value Share, by Product (2022 E)

Figure 113: East Asia Patient-Controlled Analgesia Pumps Market Value Share, by Application type (2022 E)

Figure 114: East Asia Patient-Controlled Analgesia Pumps Market Value Share, by End User (2022 E)

Figure 115: East Asia Patient-Controlled Analgesia Pumps Market Value Share, by Country (2022 E)

Figure 116: East Asia Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Product, 2022–2032

Figure 117: East Asia Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Application type, 2022–2032

Figure 118: East Asia Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by End User, 2022–2032

Figure 119: East Asia Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Country, 2022–2032

Figure 120: China Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 121: Global Vs. China Growth Comparison, 2021 - 2032

Figure 122: China Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 123: China Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 124: China Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 125: Japan Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 126: Global Vs. Japan Growth Comparison, 2021 - 2032

Figure 127: Japan Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 128: Japan Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 129: Japan Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 130: South Korea Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 131: Global Vs. South Korea Growth Comparison, 2021 - 2032

Figure 132: South Korea Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 133: South Korea Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 134: South Korea Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 135: South Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis, 2012 – 2021

Figure 136: South Asia Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Forecast, 2022-2032

Figure 137: South Asia Patient-Controlled Analgesia Pumps Market Value Share, by Product (2022 E)

Figure 138: South Asia Patient-Controlled Analgesia Pumps Market Value Share, by Application type (2022 E)

Figure 139: South Asia Patient-Controlled Analgesia Pumps Market Value Share, by End User (2022 E)

Figure 140: South Asia Patient-Controlled Analgesia Pumps Market Value Share, by Country (2022 E)

Figure 141: South Asia Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Product, 2022–2032

Figure 142: South Asia Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Application type, 2022–2032

Figure 143: South Asia Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by End User, 2022–2032

Figure 144: South Asia Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Country, 2022–2032

Figure 145: India Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 146: Global Vs. India Growth Comparison, 2021 - 2032

Figure 147: India Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 148: India Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 149: India Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 150: Indonesia Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 151: Global Vs. Indonesia Growth Comparison, 2021 - 2032

Figure 152: Indonesia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 153: Indonesia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 154: Indonesia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 155: Malaysia Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 156: Global Vs. Malaysia Growth Comparison, 2021 - 2032

Figure 157: Malaysia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 158: Malaysia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 159: Malaysia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 160: Thailand Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 161: Global Vs. Thailand Growth Comparison, 2021 - 2032

Figure 162: Thailand Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 163: Thailand Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 164: Thailand Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 165: Oceania Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis, 2012 – 2021

Figure 166: Oceania Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Forecast, 2022-2032

Figure 167: Oceania Patient-Controlled Analgesia Pumps Market Value Share, by Product (2022 E)

Figure 168: Oceania Patient-Controlled Analgesia Pumps Market Value Share, by Application type (2022 E)

Figure 169: Oceania Patient-Controlled Analgesia Pumps Market Value Share, by End User (2022 E)

Figure 170: Oceania Patient-Controlled Analgesia Pumps Market Value Share, by Country (2022 E)

Figure 171: Oceania Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Product, 2022–2032

Figure 172: Oceania Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Application type, 2022–2032

Figure 173: Oceania Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by End User, 2022–2032

Figure 174: Oceania Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Country, 2022–2032

Figure 175: Australia Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 176: Global Vs. Australia Growth Comparison, 2021 - 2032

Figure 177: Australia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 178: Australia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 179: Australia Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 180: New Zealand Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 181: Global Vs. New Zealand Growth Comparison, 2021 - 2032

Figure 182: New Zealand Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 183: New Zealand Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 184: New Zealand Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 185: Middle East & Africa Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Analysis, 2012 – 2021

Figure 186: Middle East & Africa Patient-Controlled Analgesia Pumps Market Value (US$ Mn) Forecast, 2022-2032

Figure 187: Middle East & Africa Patient-Controlled Analgesia Pumps Market Value Share, by Product (2022 E)

Figure 188: Middle East & Africa Patient-Controlled Analgesia Pumps Market Value Share, by Application type (2022 E)

Figure 189: Middle East & Africa Patient-Controlled Analgesia Pumps Market Value Share, by End User (2022 E)

Figure 190: Middle East & Africa Patient-Controlled Analgesia Pumps Market Value Share, by Country (2022 E)

Figure 191: Middle East & Africa Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Product, 2022–2032

Figure 192: Middle East & Africa Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Application type, 2022–2032

Figure 193: Middle East & Africa Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by End User, 2022–2032

Figure 194: Middle East & Africa Patient-Controlled Analgesia Pumps Market Attractiveness Analysis by Country, 2022–2032

Figure 195: GCC Countries Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 196: Global Vs. GCC Countries Growth Comparison, 2021 - 2032

Figure 197: GCC Countries Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 198: GCC Countries Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 199: GCC Countries Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 200: Turkey Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 201: Global Vs. Turkey Growth Comparison, 2021 - 2032

Figure 202: Turkey Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 203: Turkey Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 204: Turkey Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Figure 205: South Africa Patient-Controlled Analgesia Pumps Market Value Proportion Analysis, 2021

Figure 206: Global Vs. South Africa Growth Comparison, 2021 - 2032

Figure 207: South Africa Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Product, 2021 & 2032

Figure 208: South Africa Patient-Controlled Analgesia Pumps Market Share Analysis (%) by Application type, 2021 & 2032

Figure 209: South Africa Patient-Controlled Analgesia Pumps Market Share Analysis (%) by End User, 2021 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Opioid Analgesics Market

Published : October 2021

Healthcare

Analgesics Market

Published : December 2021

Healthcare

Infusion Pumps Market

Published : February 2022

Google translate

Patient-Controlled Analgesia Pumps Market